Allergan launches new product in Refresh line

Article

Refresh Optive Advanced Preservative-Free Lubricant Eye Drops from Allergan features the same formula as Refresh Optive Advanced but without a preservative.

 

Irvine, CA-Allergan, Inc. announced the launch of Refresh Optive Advanced Preservative-Free Lubricant Eye Drops. Refresh Optive Advanced Preservative-Free features the same formula that works on all three layers of the tear film to relieve dry eye symptoms as Refresh Optive Advanced but without the use of a preservative.

Refresh Optive Advanced Preservative-Free stabilizes the lipid layer to help reduce tear evaporation, hydrates the aqueous layer, and provides an advanced lubricating and protective shield to the mucin layer, while further protecting epithelial cells from hypertonic stress.

 

Some lipid-enhanced tears contain up to 2.0 uL of lipid per drop, which is up to 33 times more lipid than that found in a normal tear film. Refresh Optive Advanced Preservative-Free delivers <0.1uL of lipid per drop to stabilize the lipid layer and restore the lipid that has been lost while delivering an optimized amount for increased tolerability, according to the company.

Refresh Optive Advanced Preservative-Free is available in 30 count single-use vials and a preserved multi-dose formula. Both may be used in combination with dry eye prescription therapies and do not require shaking prior to use. 

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.